We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"... medullary thyroid cancer (10% or less of thyroid cancers are medullary). This also includes people with a syndrome called multiple endocrine ..."
"References. Original article. Wu, Y.-L. et al. Selpercatinib in early-stage RET fusionpositive nonsmall-cell lung cancer."
"... thyroid cancer rates were particularly high in those areas. Family history: Those with a family history of thyroid tumor, familial medullary thyroid ..."
"In lung cancer, Dr Khan spotlighted the LBA4 abstract examining selpercatinib (Retevmo) in RET mutation-positive patients with stage Ib to IIIa ..."
"The phase III LIBRETTO-432 trial of adjuvant therapy with the central nervous system (CNS)penetrant oral RET inhibitor selpercatinib met its ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.